STI Clinical Update Webinar– Summer 2024 Update and Review: Syphilis, Chlamydia, and Gonorrhea, County of Lake
Presented by Drs. Kelly Johnson and Kurtis Mohr Wednesday, July 24, 2024 11:00AM – 1:00PM (PDT)
CME not available for viewing the webinar recording.
Learning Objectives
Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents
Appropriately stage and treat syphilis in both pregnant and non-pregnant people
Recognize the different sequelae of sexually transmitted C. trachomatis and N. Gonorrhoeae infections & their recommended treatments
STI Clinical Update Webinar – Syphilis: A Case-Based Review and Update
March 28, 2024
9:30AM-11:00AM (MT)
Presented by Dr. Kelly Johnson
Please note: CME not available for viewing the webinar recording.
Learning Objectives:
List common causes for genital ulcerative disease
Interpret results of traditional & reverse syphilis screening algorithms
Explain the clinical significance of changes in non-treponemal titers
Name a resource for help interpreting different combinations of serologic results
2024 STI Clinical Update: San Francisco Department of Public Health (SFDPH)
Thursday, March 14, 2024
Hybrid event. Please note: CME not available for viewing the recording.
Presented by:
Dr. Oliver Bacon Medical Director, San Francisco City Clinic San Francisco Department of Public Health
Dr. Franco Chevalier Deputy Medical Director, San Francisco City Clinic San Francisco Department of Public Health
Dr. Stephanie Cohen Director, HIV/STI Prevention, Disease Control Branch, San Francisco Department of Public Health
Dr. Kelly Johnson Medical Director, California Prevention Training Center Public Health Medical Officer, STD Control Branch, California Department of Public Health
Emcee: Dr. Ina Park Principal Investigator, California Prevention Training Center
Description
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2022, and San Francisco has higher chlamydia, gonorrhea, syphilis, and HIV rates compared to the rest of the state and nation. This half-day, hybrid event will provide important updates in the field of sexual health to help providers strengthen the delivery of STI prevention and care. Hear from local experts on STI epidemiology in San Francisco, updates on Doxy-PEP implementation, recognizing dermatologic manifestations of STIs, and a lively case panel.
Learning Objectives
Summarize current STI trends in San Francisco
Be familiar with updates to STI treatment guidelines and innovations in STI prevention and diagnostics
Understand how to implement Doxy-PEP for STI prevention
Recognize common dermatologic manifestations of STIs
STI Clinical Update Webinar – Introduction to Syphilis and Congenital Syphilis: A Phoenix IHS and CAPTC Event
January 11, 2024
8:30AM-12:00PM (MST)
Presented by CAPTC Clinical Faculty
Please note: CME not available for viewing the webinar recording.
Presenters:
Sharon Adler, MD, MPH, Clinical Faculty, California Prevention Training Center
Wyatt Hanft, MD, MPH, AAHIVS, STI Fellow, California Prevention Training Center
Tamara Ooms, RN, MSN, FNP, Program Manager, California Prevention Training Center
Ina Park, MD, MS, Principal Investigator, California Prevention Training Center
Rosalyn Plotzker, MD, MPH, Clinical Faculty, California Prevention Training Center
Moderator: Kelly Johnson, MD, MPH, Medical Director, California Prevention Training Center
Learning Objectives:
Describe the varied clinical manifestations of syphilis in adults & congenital syphilis (CS) in infants
Recognize that there are two different screening algorithms used to diagnose syphilis in adults
Define adequate treatment for syphilis, including during pregnancy
List at least 3 strategies to prevent syphilis in adults and infants
STI Expert Hour Webinar – Navigating the Bicillin L-A Shortage: A Conversation with PharmD Dr. Kathy Yang
January 31, 2024
12:00PM-1:15PM (PST)
1.25 CME units at no cost
Please note: No CME available for viewing the webinar recording.
Learning Objectives
List at least 2 factors contributing to ongoing Bicillin L-A shortages
Describe a framework for prioritizing Bicillin L-A when supplies are limited
Name potential alternative treatments for syphilis in non-pregnant people
Develop a decision-making process for the treatment of syphilis when standard guidelines cannot be followed or when data is insufficient.
Meet Our Expert: Kathy Yang, PharmD, MPH
Dr. Yang is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy and the Co-Vice Dean of Clinical Innovation and Entrepreneurship at the University of California, San Francisco School of Pharmacy. She is also an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in pharmacokinetic and pharmacodynamic optimization of the treatment of multi-drug resistant infections, particularly gram-negative bacteria such as Pseudomonas aeruginosa. For the past 3 years, Dr. Yang has focused her efforts on the clinical management of COVID-19.
STI Clinical Update Humboldt County-Addressing the Rise of Syphilis: A Review of Clinical Management of Syphilis and Congenital Syphilis for Health Care Providers
Presented by Drs. Kathleen Jacobson and Wyatt Hanft
Describe the stages of syphilis and the recommended treatment and follow up for people with syphilis
Compare the traditional and reverse algorithm for syphilis screening
Please note: CME not offered for viewing the recording of the update
STI Clinical Program Updates: Mpox letter and Bicillin shortage
The California Department of Public Health (CDPH) STD Control Branch has released two new important communications on: (1) Preventing a Resurgence of Mpox Cases in California and (2) Addressing an ongoing Bicillin® L-A shortage.
CDPH is aware that – while the rate of California (CA) mpox cases has declined precipitously since its peak in August 2022 – mpox transmission has continued in CA, and other states have recently reported a resurgence of mpox cases. Accordingly, CDPH has released a new Dear Colleague Letter intended as a call to action to Californian health care providers to remain vigilant in mpox prevention, recognition, and testing. This is especially important during the upcoming 2023 spring and summer season as people gather for festivals and events, including LGBTQ Pride Month in June. Information on how to diagnose, test for, and vaccinate against mpox is included.
(2) Health Advisory: Bicillin® L-A (Benzathine Penicillin G) Shortage
The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have announced a shortage of long-acting penicillin G benzathine injectable suspension products (Bicillin® L-A), with an estimated recovery timeframe not until Q4 of 2023. This is of considerable concern in CA, as the state continues to see significant increases in syphilis — including syphilis in pregnant persons and congenital syphilis in infants. CDPH has thus issued a Health Advisory addressing the Bicillin® L-A shortage, providing a framework for prioritization of limited Bicillin® L-A supplies when necessary, and recommending doxycycline as an alternative to Bicillin® L-A in appropriate clinical scenarios.
Sincerely,
California Prevention Training Center
What are appropriate treatment intervals for late latent syphilis or syphilis of unknown duration in non-pregnant people?
Prepared by the STD Control Branch, California Department of Public Health and California Prevention Training Center. Revised February 2023.
STI Clinical Update Webinar: Syndromic Management of STIs – Part 2
Tuesday, December 6, 2022 from 12:00PM-1:15PM (PST)
Presented by Drs. Kathleen Jacobson and Kelly Johnson
A case-based approach to recognizing sexually transmitted infections, with a focus on those that disseminate outside the genital tract.
Learning Objectives
Identify various presentations of STI ulcerative disease
Understand that certain sexually transmitted infections (STIs) can disseminate outside the genital tract, sometimes causing severe disease
Recognize the varied clinical manifestations of disseminated STIs (including disseminated gonococcal infections, secondary syphilis, and mpox)
Understand how to diagnose and manage disseminated STIs
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.AcceptDisable
